0001140361-15-034627.txt : 20150908
0001140361-15-034627.hdr.sgml : 20150907
20150908194223
ACCESSION NUMBER: 0001140361-15-034627
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150903
FILED AS OF DATE: 20150908
DATE AS OF CHANGE: 20150908
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RESMED INC
CENTRAL INDEX KEY: 0000943819
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980152841
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
BUSINESS PHONE: 8587462400
MAIL ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Douglas Robert Andrew
CENTRAL INDEX KEY: 0001352232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15317
FILM NUMBER: 151097775
MAIL ADDRESS:
STREET 1: 21 ATTUNGA ROAD
CITY: NEWPORT, NEW SOUTH WALES
STATE: C3
ZIP: 2106
4
1
doc1.xml
FORM 4
X0306
4
2015-09-03
0
0000943819
RESMED INC
RMD
0001352232
Douglas Robert Andrew
RESMED INC.
9001 SPECTRUM CENTER BLVD.
SAN DIEGO
CA
92123
0
1
0
0
President and COO ResMed Inc.
ResMed Common Stock
2015-09-03
4
S
0
500
52.00
D
55338.764
I
Douglas Family Trust
ResMed Common Stock
2015-09-03
4
M
0
5833
19.25
A
61171.764
I
Douglas Family Trust
ResMed Common Stock
2015-09-03
4
S
0
5833
52.043
D
55338.764
I
Douglas Family Trust
ResMed Common Stock
75316
D
ResMed Common Stock Options
19.25
2015-09-03
4
M
0
5833
0
D
2007-02-03
2016-02-03
ResMed Common Stock
5833
23336
D
The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
Represents date options first became exercisable.
This transaction was executed in multiple trades at prices ranging from $52.00 to $52.05. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
2015-09-08